
Sus Clinicals, Inc. is a Cincinnati- and Chicago-based biotechnology company commercializing the Oncopig Cancer Model - a genetically engineered pig that develops human-like tumors on demand. Billed as the only FDA-cleared large animal cancer platform, the Oncopig carries KRAS and TP53 mutations found in more than half of human cancers, giving drug, device, and diagnostic developers a predictive testing ground that sits between the mouse and the human clinical trial. Alongside live animal supply, the company runs histology services and a tumor-tissue biorepository, and partners with CROs across the US and Europe.
The Chan Zuckerberg Initiative (CZI) is a philanthropy and technology organization founded in 2015 by Priscilla Chan and Mark Zuckerberg, structured as an LLC. Once spanning education, science, justice reform and housing, CZI has refocused on a single audacious goal: helping scientists cure, prevent or manage all disease by the end of the century. Its flagship CZ Biohub network now builds AI 'virtual cell' models, generates massive biological datasets, and ships free open-source tools so researchers everywhere can move faster.